Affordability Must Be EU’s New Drug Pricing Mantra
Executive Summary
A balance must be struck between rewarding innovation and ensuring medicines are affordable for patients, a public-interest group told the European Council in a report which said the drug industry benefits from a “web” of EU protection allowing firms to set profit-maximizing prices.